Table 3.
Survival outcomes for low-risk and high-risk groups
| Group | 2-year | 3-year | 5-year | Unadjusted | Adjusted | |||
|---|---|---|---|---|---|---|---|---|
| LRC | Total | 85.8% | 80.4% | 76.9% | P-value | 0.014* | P-value | 0.031* |
| Low-risk | 95.8% | 90.8% | 90.8% | HR | 5.46 | HR | 6.10 | |
| High-risk | 75.2% | 68.9% | 59.1% | 95% CI | 1.56–19.15 | 95% CI | 1.18–31.45 | |
| TTP | Total | 79.4% | 74.4% | 71.2% | P-value | 0.001** | P-value | 0.010* |
| Low-risk | 95.8% | 90.8% | 90.8% | HR | 7.69 | HR | 8.07 | |
| High-risk | 61.9% | 56.7% | 48.6% | 95% CI | 2.55–23.14 | 95% CI | 1.64–39.68 | |
| OS | Total | 78.3% | 71.9% | 59.4% | P-value | 0.090 | P-value | 0.083 |
| Low-risk | 92.3% | 84.6% | 65.3% | HR | 2.05 | HR | 2.33 | |
| High-risk | 63.3% | 58.5% | 58.5% | 95% CI | 0.83–5.79 | 95% CI | 0.90–6.05 | |
| CSS | Total | 85.2% | 80.6% | 77.0% | P-value | 0.010* | P-value | 0.030* |
| Low-risk | 100.0% | 95.8% | 90.2% | HR | 5.86 | HR | 6.29 | |
| High-risk | 69.1% | 63.8% | 63.8% | 95% CI | 1.66–20.71 | 95% CI | 1.19–33.10 | |
* P < 0.05; ** P < 0.01; *** P < 0.001